Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRPF1 | P55201 | 1/20 | 0.53 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.53 |
| ▸ | IDO1 | P14902 | 4/20 | 0.50 |
| ▸ | PGR | P06401 | 2/20 | 0.50 |
| ▸ | PARP1 | P09874 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 4/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | GSK3B | P49841 | 2/20 | 0.45 |
| ▸ | HTR5A | P47898 | 2/20 | 0.43 |
| ▸ | TDO2 | P48775 | 2/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30088920 | 1.00 | BRPF1 (0.53) | BRPF1CREBBPIDO1PGRPARP1 | |
| SCHEMBL19054962 | 1.00 | BRPF1 (0.53) | BRPF1CREBBPIDO1PGRPARP1 | |
| SCHEMBL7213330 | 0.86 | PGR (0.55) | BRPF1CREBBPIDO1PGRPARP1 | |
| SCHEMBL8294613 | 0.84 | BRPF1 (0.47) | BRPF1CREBBPIDO1PGRPARP1 | |
| SCHEMBL875747 | 0.84 | BRPF1 (0.47) | BRPF1CREBBPIDO1PGRPARP1 | |
| SCHEMBL14169780 | 0.84 | CREBBP (0.65) | BRPF1CREBBPIDO1PGRPARP1 | |
| SCHEMBL13366003 | 0.81 | HTR5A (0.48) | BRPF1CREBBPMAPTGAAHTR5A | |
| SCHEMBL31474673 | 0.81 | HTR5A (0.48) | BRPF1CREBBPMAPTGAAHTR5A | |
| SCHEMBL6220534 | 0.81 | BRPF1 (0.52) | BRPF1CREBBPIDO1PARP1MAPT | |
| SCHEMBL5496567 | 0.79 | PDK2 (0.44) | BRPF1CREBBPIDO1PGRMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 357 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4747627-A1 | METHODS AND SYSTEMS FOR PREDICTIVE CLASSIFICATION BY MASS SPECTROMETRY AND TRAINED LARGE SPECTRAL MODELS | Matterworks Inc (US) | 2026-05-27 | — | — | EP | claimed |
| WO-2025019764-A1 | METHODS AND SYSTEMS FOR PREDICTIVE CLASSIFICATION BY MASS SPECTROMETRY AND TRAINED LARGE SPECTRAL MODELS | MATTERWORKS INC (US) | 2025-01-23 | — | — | WO | claimed |
| CN-118668266-A | Cyanide-free electroless gold plating solution applied to wafer | 深圳市溢诚电子科技有限公司 | 2024-09-20 | — | — | CN | claimed |
| CN-115701440-B | Polyimide composite film, preparation method thereof and electronic equipment | 华为技术有限公司 | 2024-07-30 | — | — | CN | claimed |
| CN-116656352-B | Eutectic solvent and preparation method and application thereof | 河北科技大学 | 2024-05-10 | — | — | CN | claimed |
| CN-116656352-A | Eutectic solvent and preparation method and application thereof | 河北科技大学 | 2023-08-29 | — | — | CN | claimed |
| US-20230137741-A1 | METHODS AND COMPOSITIONS FOR ANALYTE QUANTIFICATION | MATTERWORKS INC | 2023-05-04 | — | — | US | claimed |
| WO-2023077166-A1 | METHODS AND COMPOSITIONS FOR ANALYTE QUANTIFICATION | MATTERWORKS INC (US) | 2023-05-04 | — | — | WO | claimed |
| US-20160331725-A1 | USE OF COMPOUNDS THAT ARE ABLE TO INCREASE THE SERUM IGF-1 LEVEL FOR THE PREPARATION OF A THERAPEUTICAL COMPOSITION FOR TREATMENT OF VARIOUS DISEASE STATES ASSOCIATED WITH A REDUCED IGF-1 SERUM LEVEL IN HUMANS AND ANIMALS | VEIJLEN N.V. | 2016-11-17 | — | — | US | claimed |
| US-20150374662-A1 | INHIBITORS OF BETA-CATENIN IN TREATMENT OF COLORECTAL CANCER | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2015-12-31 | — | — | US | claimed |
| CN-1253543-A | Process for producing ketoprofen and 5-benzoyl-3-methyl-2-indolinone | MEDICAL INFORMATION SERVICES I (JP) | 2000-05-17 | — | — | CN | claimed |
| EP-0990637-A1 | PROCESS FOR PRODUCING KETOPROFEN AND 5-BENZOYL-3-METHYL-2-INDOLINONE | Medical Information Services, Inc. (JP) | 2000-04-05 | — | — | EP | claimed |
| EP-0460679-B1 | Endothelin antagonistic peptide derivatives | BANYU PHARMA CO LTD (JP) | 1998-10-28 | — | — | EP | claimed |
| US-5691315-A | CARDIOVASCULAR DISORDERS; VASODILATOR; BRONCHODILATOR | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1997-11-25 | — | — | US | claimed |
| US-5470833-A | Vasodilators, bronchodilators | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1995-11-28 | — | — | US | claimed |
| US-5444152-A | Vasolidator or bronchodilator | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1995-08-22 | — | — | US | claimed |
| EP-0626174-A2 | Methods and compositions for the prophylactic and/or therapeutic treatment of organ hypofunction | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1994-11-30 | — | — | EP | claimed |
| EP-0460679-A2 | Endothelin antagonistic peptide derivatives | Banyu Pharmaceutical Co., Ltd. (JP) | 1991-12-11 | — | — | EP | claimed |
| US-4845281-A | Method of preparing ketoprofen | BLASCHIM, S.P.A. (IT) | 1989-07-04 | — | — | US | claimed |
| EP-0309009-A1 | Process for preparing ketoprofen | Nobel Chemicals AB (SE) | 1989-03-29 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150374662-A1 | INHIBITORS OF BETA-CATENIN IN TREATMENT OF COLORECTAL CANCER | CTNNB1, APC, CTNNBL1 | BRPF1 2306/4885CREBBP 179/4885IDO1 3719/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.